Efficacy of 25% diluted fluticasone propionate 0.05% cream as wet-wrap treatment in cutaneous mastocytosis

Dermatology

Volumn 214, Issue 4, 2007, Pages 333-335

  Heide, Rogier ^a   De Waard Van Der Spek, Flora B ^b   Den Hollander, Jan C ^b   Tank, Bhupendra ^b   Oranje, Arnold P ^b  

^a MCA   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Fluticasone propionate 25 diluted; Mastocytosis; Wet wrap

Indexed keywords

FLUTICASONE PROPIONATE;

ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CREAM; DRUG EFFICACY; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; SCORING SYSTEM; SKIN BIOPSY; TELANGIECTASIA; TREATMENT DURATION; TREATMENT OUTCOME; URTICARIA PIGMENTOSA;

ADMINISTRATION, TOPICAL; ADULT; ANDROSTADIENES; ANTI-INFLAMMATORY AGENTS; CASE-CONTROL STUDIES; CHILD; EMOLLIENTS; HUMANS; MASTOCYTOSIS, CUTANEOUS; OCCLUSIVE DRESSINGS; PILOT PROJECTS; TREATMENT OUTCOME;

EID: 34247544273     PISSN: 10188665     EISSN: None     Source Type: Journal    
DOI: 10.1159/000100885     Document Type: Article

References (13)

1. Valent P, Horny HP, Escribano L, et al: Diagnostic criteria and classification of mastocytosis: a consensus proposal. Leuk Res 2001;25:603-625.
2. Escribano L, Akin C, Castells M, et al: Mastocytosis: current concepts in diagnosis and treatment. Ann Hematol 2002;81:677-690.
3. Heide R, Tank B, Oranje AP: Mastocytosis in childhood. Pediatr Dermatol 2002;19:375-381.
4. Walker T, von Komorowski G, Scheurlen W, Dorn-Beineke A, Back W, Bayerl C: Neonatal mastocytosis with pachydermic bullous skin without c-Kit 816 mutation. Dermatology 2006;212:70-72.
5. Tharp MD, Chan IJ: Mastocytosis. Adv Dermatol 2003;19:207-236.
6. Mateo JR: Mastocytoma: topical corticosteroid treatment. J Eur Acad Dermatol Venereol 2001;14:492-494.
7. Oranje AP, Wolkerstofer A, de Waard-van der Spek FB: Treatment of erythrodermic atopic dermatitis with 'wet-wrap' fluticasone propionate 0.05% cream: emollient 1:1 dressings. J Dermatol Treatm 1999;10:73-74.
8. Foelster-Holst R, Nagel F, Zoellner P, Spaeth D: Efficacy of crisis intervention treatment with topical corticosteroid prednicarbat with and without partial wet-wrap dressing in atopic dermatitis. Dermatology 2006;212:66-69.
9. Heide R, Middelkamp Hup MA, Mulder PGH, Oranje AP; Mastocytosis study group Rotterdam: clinical scoring of cutaneous mastocytosis. Acta Derm Venereol 2001;81:273-276.
10. Leder LD: Uber die selective fermentcytochemische Darstellung von neutrophilen myeloischen Zellen und Gewebsmastzellen im Paraffinschnitt. Klin Wochenschr 1964;42:553.
11. Van Toorenenbergen AW, Oranje AP: Comparison of serum tryptase and urine N-methylhistamine in patients with suspected mastocytosis. Clin Chim Acta 2005;359:72-77.
12. Devillers AC, de Waard-van der Spek FB, Mulder PG, Oranje AP: Treatment of refractory atopic dermatitis using 'wet-wrap' dressings and diluted corticosteroids: results of standardized treatment in both children and adults. Dermatology 2002;204:50-55.
13. Devillers ACA, Oranje AP: Efficacy and safety of 'wet-wrap' dressings as an intervention treatment in children with severe and/or refractory atopic dermatitis: a critical review of the literature. Br J Dermatol 2006;154:579-585.